<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11">
 <label>11</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Garcia-Del-Muro</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Lopez-Pousa</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Maurel</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Martin</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Martinez-Trufero</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Casado</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study</article-title>. 
  <source>J Clin Oncol</source> (
  <year>2011</year>) 
  <volume>29</volume>(
  <issue>18</issue>):
  <page-range>2528â€“33</page-range>. 
  <pub-id pub-id-type="doi">10.1200/JCO.2010.33.6107</pub-id>
 </mixed-citation>
</ref>
